APA (7th ed.) Citation

A, P., M, K., D, K., & R, D. (2020). Real-world clinical outcomes of first-generation and second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large cohort of European non-small-cell lung cancer patients. ESMO open, 5(6), e001011. https://doi.org/10.1136/esmoopen-2020-001011

Chicago Style (17th ed.) Citation

A, Pluzanski, Krzakowski M, Kowalski D, and Dziadziuszko R. "Real-world Clinical Outcomes of First-generation and Second-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in a Large Cohort of European Non-small-cell Lung Cancer Patients." ESMO Open 5, no. 6 (2020): e001011. https://doi.org/10.1136/esmoopen-2020-001011.

MLA (9th ed.) Citation

A, Pluzanski, et al. "Real-world Clinical Outcomes of First-generation and Second-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in a Large Cohort of European Non-small-cell Lung Cancer Patients." ESMO Open, vol. 5, no. 6, 2020, p. e001011, https://doi.org/10.1136/esmoopen-2020-001011.